Liver Cirrhosis
Nova Science Publishers Inc (Verlag)
978-1-61209-248-5 (ISBN)
This book presents topical research in the study of liver cirrhosis, including etiologic types of end stage chronic liver disease; hepatocellular carcinoma screening in the cirrhotic patient; hepatic myofibroblasts and their role in liver fibrogenesis; the role of trace elements in the pathogenesis of liver cirrhosis and cell-based therapy for liver cirrhosis.
Preface; Thalidomide & its Analogs: A Potential Immunomodulatory Alternative for Treating Liver Diseases & Cirrosis; Role of the Energy State of Liver Cell in Cirrhosis Development & Treatment; End Stage Chronic Liver Disease: Yesterday, Today & Tomorrow; Hepatocellular Carcinoma Screening, Diagnosis & Management in the Cirrhotic Patient: A Western Review & Recommendations; Hepatic Myofibroblasts: Origin & Role in Liver Fibrogenesis; The Role of Surgery in Patients with liver Cirrhosis; Primary Biliary Cirrhosis: An Infection Triggered Disease?; Surgical Treatment of Portal Hypertension; Thalidomide & its Analogs: An Immunomodulatory Alternative for Treating Liver Diseases & Cirrhosis; Cell-Based Therapy of Liver Cirrhosis; Zinc, Copper, Manganese & Magnesium in Liver Cirrhosis; Index.
| Zusatzinfo | Illustrations |
|---|---|
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 260 x 180 mm |
| Gewicht | 622 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hepatologie |
| ISBN-10 | 1-61209-248-9 / 1612092489 |
| ISBN-13 | 978-1-61209-248-5 / 9781612092485 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
